Nitric oxide--biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosis.

[1]  S. Moncada,et al.  Direct measurement of nitric oxide in human beings , 1995, The Lancet.

[2]  R. Heath.  The biology of nitric oxide 3. Physiological and clinical aspects: Edited by S Moncada, M Feelisch, R Busse and E A Higgs. pp 551. Portland Press, London. 1994 ISBN 1-85578-063-1 , 1995 .

[3]  S. Moncada,et al.  Megakaryocytes from patients with coronary atherosclerosis express the inducible nitric oxide synthase. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[4]  J. Mehta,et al.  Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. , 1995, The Journal of laboratory and clinical medicine.

[5]  P. Ganz,et al.  Systemic nature of endothelial dysfunction in atherosclerosis. , 1995, The American journal of cardiology.

[6]  S. Moncada,et al.  Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[7]  K. Kugiyama,et al.  LPC in oxidized LDL elicits vasocontraction and inhibits endothelium- dependent relaxation. , 1994, The American journal of physiology.

[8]  P. Tsao,et al.  L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[9]  U. Walter,et al.  Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition. , 1994, European journal of biochemistry.

[10]  A. Lukaszyk,et al.  Nitric oxide synthase inhibition and platelet function. , 1994, Thrombosis research.

[11]  D. Tsikas,et al.  L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. , 1994, Clinical science.

[12]  T. Dawson,et al.  Gases as biological messengers: nitric oxide and carbon monoxide in the brain , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  J. Hardebo,et al.  The role of nitric oxide in the cerebrovascular flow response to stimulation of postganglionic parasympathetic nerves in the rat. , 1994, Journal of the autonomic nervous system.

[14]  J. Vanderkooi,et al.  Nitric oxide diffusion coefficients in solutions, proteins and membranes determined by phosphorescence. , 1994, Biochimica et biophysica acta.

[15]  S. Moncada,et al.  Comparative pharmacology of analogues of S‐nitroso‐N‐acetyl‐dl‐penicillamine on human platelets , 1994, British journal of pharmacology.

[16]  M. A. Moro,et al.  Paradoxical fate and biological action of peroxynitrite on human platelets. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C Lenfant,et al.  NHLBI funding policies. Enhancing stability, predictability, and cost control. , 1994, Circulation.

[18]  B. Mutus,et al.  Isolation of nitric oxide synthase from human platelets. , 1994, Biochimica et biophysica acta.

[19]  M. Nakatsuka,et al.  Selective inhibition of the 12-lipoxygenase pathway of arachidonic acid metabolism by L-arginine or sodium nitroprusside in intact human platelets. , 1994, Biochemical and biophysical research communications.

[20]  R. Cohen,et al.  Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[21]  R. Polanowska-Grabowska,et al.  Role of cyclic nucleotides in rapid platelet adhesion to collagen. , 1994, Blood.

[22]  D. S. Houston,et al.  Influence of endothelium-derived relaxing factor on platelet function and hemostasis in vivo. , 1994, Thrombosis research.

[23]  K. Ivanova,et al.  Soluble Guanylyl Cyclase and Platelet Function a , 1994, Annals of the New York Academy of Sciences.

[24]  S Moncada,et al.  Nitric oxide synthases in mammals. , 1994, The Biochemical journal.

[25]  W. A. Bradley,et al.  Superoxide and peroxynitrite in atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Tsao,et al.  Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. , 1994, Journal of the American College of Cardiology.

[27]  P G Anderson,et al.  Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. , 1994, Biological chemistry Hoppe-Seyler.

[28]  J. Launay,et al.  Increase of human platelet serotonin uptake by atypical histamine receptors. , 1994, The American journal of physiology.

[29]  J. Brien,et al.  Selective sequestration of nitric oxide by subcellular components of vascular smooth muscle and platelets: relationship to nitric oxide stimulation of the soluble guanylyl cyclase. , 1993, Canadian journal of physiology and pharmacology.

[30]  Joseph Loscalzo,et al.  A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds , 1993, Nature.

[31]  S. Moncada,et al.  Direct electrochemical measurement of nitric oxide released from human platelets. , 1993, Biochemical and biophysical research communications.

[32]  M. Marletta,et al.  Oxidation of NG-hydroxy-L-arginine by nitric oxide synthase: evidence for the involvement of the heme in catalysis. , 1993, Biochemical and biophysical research communications.

[33]  C. Lau,et al.  Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients , 1993, The Lancet.

[34]  B. Brüne,et al.  Efflux of cyclic GMP from activated human platelets. , 1993, Molecular pharmacology.

[35]  D. Hajjar,et al.  Cholesterol enrichment of arterial smooth muscle cells upregulates cytokine-induced nitric oxide synthesis. , 1993, Biochemical and biophysical research communications.

[36]  N. Ishida,et al.  Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. , 1993, Biochemical and biophysical research communications.

[37]  M. Lewis,et al.  Induction of a calcium‐independent NO synthase by hypercholesterolaemia in the rabbit , 1993, British journal of pharmacology.

[38]  M. Condorelli,et al.  Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation. , 1992, Circulation research.

[39]  F. Kiechle,et al.  Oxidation of nitric oxide by oxygen in biological systems monitored by porphyrinic sensor. , 1992, Biochemical and biophysical research communications.

[40]  P. Tsao,et al.  Cellular mechanisms of atherogenesis and the effects of nitric oxide , 1992 .

[41]  H. Anderson,et al.  Endogenous Nitric Oxide Protects Against Platelet Aggregation and Cyclic Flow Variations in Stenosed and Endothelium‐Injured Arteries , 1992, Circulation.

[42]  J. Cooke,et al.  L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. , 1992, The Journal of clinical investigation.

[43]  C. Nathan,et al.  Nitric oxide as a secretory product of mammalian cells , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  K. Schappert,et al.  Molecular cloning and characterization of human endothelial nitric oxide synthase , 1992, FEBS letters.

[45]  N. Flavahan.  Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity. , 1992, Circulation.

[46]  J. Johansson,et al.  Cyclic GMP increases the rate of the calcium extrusion pump in intact human platelets but has no direct effect on the dense tubular calcium accumulation system. , 1992, Biochimica et biophysica acta.

[47]  M. Rand,et al.  NITRERGIC TRANSMISSION: NITRIC OXIDE AS A MEDIATOR OF NON‐ADRENERGIC, NON‐CHOLINERGIC NEURO‐EFFECTOR TRANSMISSION , 1992, Clinical and experimental pharmacology & physiology.

[48]  H. Drexler,et al.  Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine , 1991, The Lancet.

[49]  T. Cebula,et al.  DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. , 1991, Science.

[50]  S. Moncada,et al.  Synthesis of Nitric Oxide by the Haemocytes of the American Horseshoe Crab (Limulus polyphemus) , 1991 .

[51]  V. Sagach,et al.  Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat , 1991, Neuroscience Letters.

[52]  K. Herbaczyńska-Cedro,et al.  NG-monomethyl-L-arginine increases platelet deposition on damaged endothelium in vivo. A scanning electron microscopic study. , 1991, Thrombosis research.

[53]  J. Covès,et al.  Inactivation of ribonucleotide reductase by nitric oxide. , 1991, Biochemical and biophysical research communications.

[54]  A. Marcus,et al.  Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism. , 1991, Blood.

[55]  S. Snyder,et al.  Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase , 1991, Nature.

[56]  P. Kubes,et al.  Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[57]  T Sandor,et al.  Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis. , 1991, Circulation research.

[58]  P. Moore,et al.  The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit , 1991, British journal of pharmacology.

[59]  S. Moncada,et al.  Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. , 1990, Biochemical and biophysical research communications.

[60]  S. Moncada,et al.  Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[61]  J. Cooke,et al.  L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. , 1990, Circulation research.

[62]  S. Moncada,et al.  Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. , 1990, Biochemical and biophysical research communications.

[63]  J. Loscalzo,et al.  Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. , 1990, The Journal of biological chemistry.

[64]  M. Yacoub,et al.  Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries , 1990, The Lancet.

[65]  S. Moncada,et al.  Characterization of the l‐arginine: nitric oxide pathway in human platelets , 1990, British journal of pharmacology.

[66]  J. Gerrard,et al.  Inhibition of intravascular platelet aggregation by endothelium-derived relaxing factor: reversal by red blood cells. , 1990, Blood.

[67]  P. Leff,et al.  Inhibition of Collagen‐ and ADP‐Induced Platelet Aggregation by Substance P In Vivo: Involvement of Endothelium‐Derived Relaxing Factor , 1990, Journal of cardiovascular pharmacology.

[68]  S. Moncada,et al.  An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[69]  D. Harrison,et al.  Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide , 1990, Nature.

[70]  R. Haslam,et al.  Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. , 1990, Molecular pharmacology.

[71]  C. Nathan,et al.  FAD and GSH participate in macrophage synthesis of nitric oxide. , 1990, Biochemical and biophysical research communications.

[72]  K. Kugiyama,et al.  Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins , 1990, Nature.

[73]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[74]  A. Bielawska,et al.  Cyclic GMP analogs inhibit gamma thrombin-induced arachidonic acid release in human platelets. , 1989, Biochemical and biophysical research communications.

[75]  R. Busse,et al.  EDRF Increases Cyclic GMP in Platelets During Passage Through the Coronary Vascular Bed , 1989, Circulation research.

[76]  M. Marletta,et al.  Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor. , 1989, The Journal of biological chemistry.

[77]  S. Moncada,et al.  EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MAN , 1989, The Lancet.

[78]  U. Förstermann,et al.  Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP. , 1989, European journal of pharmacology.

[79]  A. Hassid,et al.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[80]  S Moncada,et al.  Role of endothelium-derived nitric oxide in the regulation of blood pressure. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[81]  C. Venturini,et al.  Thrombin induced platelet adhesion to endothelium is modified by endothelial derived relaxing factor (EDRF). , 1989, Biochemical and biophysical research communications.

[82]  S. Moncada,et al.  A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. , 1989, Biochemical and biophysical research communications.

[83]  H. Shimokawa,et al.  Dietary cod-liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. , 1988, Circulation.

[84]  P. Moore,et al.  Endothelium-derived relaxing factor inhibits platelet aggregation in human whole blood in vitro and in the rat in vivo. , 1988, European Journal of Pharmacology.

[85]  M. Lewis,et al.  In vivo EDRF activity influences platelet function , 1988, British journal of pharmacology.

[86]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[87]  J. Vane,et al.  Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[88]  G. Dusting,et al.  Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin. , 1988, Thrombosis research.

[89]  L. Ignarro,et al.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[90]  S Moncada,et al.  The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. , 1987, Biochemical and biophysical research communications.

[91]  S. Moncada,et al.  ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM , 1987, The Lancet.

[92]  S. Moncada,et al.  The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide , 1987, British journal of pharmacology.

[93]  S. Moncada,et al.  Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets , 1987, British journal of pharmacology.

[94]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[95]  M. Lewis,et al.  Endothelium‐derived relaxing factor inhibits in vitro platelet aggregation , 1987, British journal of pharmacology.

[96]  G. H. Nelson,et al.  Laser-induced endothelial damage inhibits endothelium-dependent relaxation in the cerebral microcirculation of the mouse. , 1987, Circulation research.

[97]  J. Hibbs,et al.  Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. , 1987, Science.

[98]  P. Ganz,et al.  Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.

[99]  D. Harrison,et al.  Atherosclerosis Impairs Endothelium‐Dependent Vascular Relaxation to Acetylcholine and Thrombin in Primates , 1986, Circulation research.

[100]  H. Ogawa,et al.  Effects of intracoronary injection of acetylcholine on coronary arterial diameter. , 1986, The American journal of cardiology.

[101]  S. Moncada,et al.  Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor , 1986, Nature.

[102]  A. Herman,et al.  Effect of Hypercholesterolemia on Vascular Reactivity in the Rabbit: I. Endothelium‐Dependent and Endothelium‐Independent Contractions and Relaxations in Isolated Arteries of Control and Hypercholesterolemic Rabbits , 1986, Circulation research.

[103]  S. Nakashima,et al.  Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human platelets. , 1986, Biochemical and biophysical research communications.

[104]  M. Marletta,et al.  Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[105]  C. Kappagoda,et al.  Cholesterol feeding impairs endothelium-dependent relaxation of rabbit aorta. , 1985, Canadian journal of physiology and pharmacology.

[106]  H. Christensen,et al.  Cationic amino acid transport into cultured animal cells. I. Influx into cultured human fibroblasts. , 1982, The Journal of biological chemistry.

[107]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[108]  F. DeRubertis,et al.  Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation. , 1978, The Journal of biological chemistry.

[109]  Quansheng Zhou,et al.  Nitric oxide release from resting human platelets. , 1995, Thrombosis research.

[110]  J. Stamler,et al.  S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[111]  J. Lancaster,et al.  Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: A molecular mechanism regulating cellular proliferation that targets intracellular iron , 1990 .

[112]  U Walter,et al.  Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. , 1989, Reviews of physiology, biochemistry and pharmacology.

[113]  J. T. Shepherd,et al.  Vasodilatation : vascular smooth muscle, peptides, autonomic nerves, and endothelium , 1988 .

[114]  P. D. Henry,et al.  Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. , 1987, The Journal of clinical investigation.

[115]  R Busse,et al.  Crucial role of endothelium in the vasodilator response to increased flow in vivo. , 1986, Hypertension.